'Cannot cut corners': WHO on approving India's Covaxin shot

Updated : Oct 18, 2021 22:00
|
Editorji News Desk

The World Health Organization on Monday said it cannot ‘cut corners' in considering Bharat Biotech’s request for an emergency-use listing for its COVID-19 shot.

Further, the world health body has asked for more data from Bharat Biotech which started sharing data with the WHO from early July.

Also Read Covid Complications: The higher the BMI, the bigger the risk

Bharat Biotech’s Covid-19 vaccine, Covaxin was given emergency-use authorisation in India in January even before the completion of a late-stage trial, which later found the shot to be 78% efficacious.

Without a WHO nod, the two-dose Covaxin is unlikely to be accepted as a valid vaccine around the world and would complicate travel plans for Indians who have taken it.

Covaxin accounts for 11% of the 985.5 million total doses administered in India

India is the world’s biggest producer of vaccines, with a capacity to make more than 3 billion COVID shots a year.

Bharat BiotechCovaxinWHO

Recommended For You

editorji | India

Omar Abdullah meets Amit Shah, discusses J&K's statehood restoration

editorji | India

Unprecedented fracas on Parliament premises, 2 BJP MPs injured; NDA, Congress file police complaints

editorji | World

Around 70 Hindu pilgrims arrive in Pak from India to perform religious rituals at Katas Raj temples

editorji | India

Delhi Elections: MCD passes proposal to release Rs 25.35 crore for preparations

editorji | India

Union Home Minister Amit Shah reviews J&K security situation